NuWave Investment Management’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$194K Buy
+5,980
New +$247K 0.22% 156
2022
Q2
Sell
-905
Closed -$63K 284
2022
Q1
$63K Sell
905
-5,860
-87% -$428K 0.08% 214
2021
Q4
$527K Buy
6,765
+5,283
+356% +$466K 0.6% 52
2021
Q3
$141K Buy
+1,482
New +$156K 0.16% 173
2021
Q1
Sell
-359
Closed -$48K 323
2020
Q4
$48K Buy
359
+343
+2,144% +$41.5K 0.06% 249
2020
Q3
$2K Buy
+16
New +$1.38K ﹤0.01% 430

Other funds holding EXAS

NuWave Investment Management's EXAS Position: Q3 2022 in Review

NuWave Investment Management opened a new position in Exact Sciences (EXAS) in Q3 2022: 5,980 shares worth $194K. The stake represents 0.22% of the portfolio and ranks #156 among its holdings. This is a return to the name: NuWave Investment Management previously reported a position in EXAS as recently as Q1 2022.

NuWave Investment Management first reported a position in EXAS in Q3 2020 and has held it in 6 quarters since. The position peaked at $527K in Q4 2021. 480 funds tracked by Wall St. Rank hold EXAS as of Q3 2022.

  • NuWave Investment Management held 5,980 shares of Exact Sciences worth $194K as of Q3 2022.
  • Exact Sciences was a new NuWave Investment Management position in Q3 2022.
  • Exact Sciences made up 0.22% of NuWave Investment Management's portfolio in Q3 2022, its #156 holding.
  • NuWave Investment Management first reported a position in Exact Sciences in Q3 2020 and has held it in 6 quarters since.
  • NuWave Investment Management's Exact Sciences position peaked at $527K in Q4 2021.
  • 480 funds tracked by Wall St. Rank held Exact Sciences as of Q3 2022.

Based on NuWave Investment Management's 13F filing for Q3 2022, filed 21 Oct 2022.